Home › Scleroderma › Texas › Houston
Pag-aaral pangklinika para sa Scleroderma sa Houston, TX
9 pag-aaral para sa Scleroderma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Houston (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Nagre-recruitPhase 1
- UT MD Anderson Cancer Center, Houston
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
Nagre-recruitPhase 3
- The University of Texas Health Science Center at Houston, Houston
Platform Clinical Study for Conquering Scleroderma
Nagre-recruitPhase 2
- University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics, Houston
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Nagre-recruitPhase 1/2
- Nkarta Investigational Site, Houston
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Nagre-recruitPhase 2
- Artiva Investigational Site Bellaire, Bellaire · 7 mi ang layo
A Study of Microbiome Transplantation for the Treatment of Constipation and/or Significant Bloating in Patients With Systemic Sclerosis
Nagre-recruitPhase 2
- The University of Texas Health Science Center at Houston, Houston
Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
Nagre-recruitPhase 1/2
- MD Anderson Cancer Center, Houston
- The University of Texas Health Science Center at Houston, Houston
Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis
Nagre-recruit
- The University of Texas Health Science Center at Houston, Houston
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
Nagre-recruitPhase 2
- aTyr Investigative Site, Houston
Pag-aaral para sa Scleroderma sa ibang lungsod
- New York City, NY11 pag-aaral
- Chicago, IL10 pag-aaral
- Ann Arbor, MI10 pag-aaral
- Durham, NC7 pag-aaral
- Boston, MA7 pag-aaral
- Los Angeles, CA7 pag-aaral
- Baltimore, MD6 pag-aaral
- Philadelphia, PA6 pag-aaral
- New Orleans, LA6 pag-aaral
- Pittsburgh, PA5 pag-aaral
- Dallas, TX5 pag-aaral
- Kansas City, KS4 pag-aaral
Iba pang pag-aaral sa Houston
- Non-Small Cell Lung Cancer145 pag-aaral
- Kanser sa Suso126 pag-aaral
- Kanser (lahat ng uri)123 pag-aaral
- Metastatic Cancer104 pag-aaral
- Colorectal Cancer102 pag-aaral
- Kanser sa Ovary89 pag-aaral
- Acute Myeloid Leukemia86 pag-aaral
- Kanser sa Baga78 pag-aaral
- Kanser sa Prostate76 pag-aaral
- Kanser ng Endometrium68 pag-aaral
- Kanser sa Pancreas62 pag-aaral
- Melanoma59 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.